Background: Historically, limited sensitivity associated with traditional immunoassay methods has prevented the use of brain-specific proteins as blood biomarkers of traumatic brain injury (TBI) during triage, as these proteins exhibit low circulating concentrations. Digital ELISA is a newly-developed technique that is up to 1000 times more sensitive than conventional ELISA methods. The purpose of this study was to determine whether the use of digital ELISA over conventional ELISA improves the performance of brain-specific proteins as blood biomarkers of TBI during triage. Methods: Blood was sampled from TBI patients (n = 13) at emergency department admission, as well as from neurologically normal controls (n = 72). Serum levels of two brain-specific proteins, neurofilament light chain (NfL) and Tau, were measured via digital ELISA. Estimated conventional ELISA measures were generated by adjusting values according to the lower limits of detection achievable with commercially available conventional ELISA assays, and receiver operating characteristic (ROC) analysis was used to compare the diagnostic performance of digital ELISA measures to estimated conventional ELISA measures in terms of their ability to discriminate between TBI patients and controls. Results: Used in combination, digital ELISA measures of NfL and Tau could discriminate between groups with 100% sensitivity and 91.7% specificity. Estimated conventional ELISA measures could only discriminate between groups with 7.7% sensitivity and 94.4% specificity. This difference in diagnostic performance was statistically significant when comparing areas under ROC curves.Conclusions: The use of digital ELISA over conventional ELISA methods improves the diagnostic performance of circulating brain-specific proteins for detection of TBI during triage.
Background: Historically, limited sensitivity associated with traditional immunoassay methods has prevented the use of brain-specific proteins as blood biomarkers of traumatic brain injury (TBI) during triage, as these proteins exhibit low circulating concentrations. Digital ELISA is a newly-developed technique that is up to 1000 times more sensitive than conventional ELISA methods. The purpose of this study was to determine whether the use of digital ELISA over conventional ELISA improves the performance of brain-specific proteins as blood biomarkers of TBI during triage. Methods: Blood was sampled from TBIpatients (n = 13) at emergency department admission, as well as from neurologically normal controls (n = 72). Serum levels of two brain-specific proteins, neurofilament light chain (NfL) and Tau, were measured via digital ELISA. Estimated conventional ELISA measures were generated by adjusting values according to the lower limits of detection achievable with commercially available conventional ELISA assays, and receiver operating characteristic (ROC) analysis was used to compare the diagnostic performance of digital ELISA measures to estimated conventional ELISA measures in terms of their ability to discriminate between TBIpatients and controls. Results: Used in combination, digital ELISA measures of NfL and Tau could discriminate between groups with 100% sensitivity and 91.7% specificity. Estimated conventional ELISA measures could only discriminate between groups with 7.7% sensitivity and 94.4% specificity. This difference in diagnostic performance was statistically significant when comparing areas under ROC curves.Conclusions: The use of digital ELISA over conventional ELISA methods improves the diagnostic performance of circulating brain-specific proteins for detection of TBI during triage.
Entities:
Keywords:
SiMoA; Single molecule array; biomarkers; concussion; molecular diagnostics; triage
Authors: Florence C M Reith; Ruben Van den Brande; Anneliese Synnot; Russell Gruen; Andrew I R Maas Journal: Intensive Care Med Date: 2015-11-12 Impact factor: 17.440
Authors: Grant L Iverson; Preethi J Reddi; Jussi P Posti; Anna-Kerttu Kotilainen; Olli Tenovuo; Juha Öhman; Henrik Zetterberg; Kaj Blennow; Teemu M Luoto Journal: J Neurotrauma Date: 2019-04-23 Impact factor: 5.269
Authors: Grant C O'Connell; Madison B Treadway; Connie S Tennant; Noelle Lucke-Wold; Paul D Chantler; Taura L Barr Journal: Transl Stroke Res Date: 2018-03-17 Impact factor: 6.829
Authors: Nicola Marchi; Peter Rasmussen; Miranda Kapural; Vince Fazio; Kelly Kight; Marc R Mayberg; Andrew Kanner; Barbara Ayumar; Ben Albensi; Marco Cavaglia; Damir Janigro Journal: Restor Neurol Neurosci Date: 2003 Impact factor: 2.406
Authors: Grant C O'Connell; Madison B Treadway; Ashley B Petrone; Connie S Tennant; Noelle Lucke-Wold; Paul D Chantler; Taura L Barr Journal: Lab Med Date: 2017-11-08
Authors: Venkata Yelleswarapu; Joshua R Buser; Margalit Haber; Jonathan Baron; Eshwar Inapuri; David Issadore Journal: Proc Natl Acad Sci U S A Date: 2019-02-14 Impact factor: 11.205
Authors: Grant C O'Connell; Megan L Alder; Christine G Smothers; Julia H C Chang Journal: Proc Natl Acad Sci U S A Date: 2020-08-06 Impact factor: 11.205
Authors: Ziyi He; Justin Huffman; Kathrine Curtin; Krista L Garner; Elizabeth C Bowdridge; Xiaojun Li; Timothy R Nurkiewicz; Peng Li Journal: Anal Chem Date: 2020-12-16 Impact factor: 6.986
Authors: Davran Sabirov; Sergei Ogurcov; Irina Baichurina; Nataliya Blatt; Albert Rizvanov; Yana Mukhamedshina Journal: Front Mol Biosci Date: 2022-09-29